Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Green

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Sensors (Basel, Switzerland)|July 27, 2024
Rapid Detection of Cleanliness on Direct Bonded Copper Substrate by Using UV Hyperspectral ImagingMona Knoblich, Mohammad Al Ktash, Frank Wackenhut, et al.
Breast Cancer Research and Treatment|January 29, 2016
The effect of resistance training on markers of immune function and inflammation in previously sedentary women recovering from breast cancer: a randomized controlled trialAmanda D Hagstrom, Paul W M Marshall, Chris Lonsdale, et al.
Sensors (Basel, Switzerland)|November 13, 2021
UV Hyperspectral Imaging as Process Analytical Tool for the Characterization of Oxide Layers and Copper States on Direct Bonded CopperMohammad Al Ktash, Mona Stefanakis, Tim Englert, et al.
Blood|November 18, 2004
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen deliveryMax Schnurr, Qiyuan Chen, Amanda Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumorsEugene Maraskovsky, Sigrid Sjölander, Debbie P Drane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancerWen-Son Hsieh, Ross Soo, Bee-Keow Peh, et al.
Journal of Medicinal Chemistry|March 19, 2004
2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activityShudong Wang, Christopher Meades, Gavin Wood, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvantQiyuan Chen, Heather Jackson, Phillip Parente, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2004
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humansIan D Davis, Weisan Chen, Heather Jackson, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Sensors (Basel, Switzerland)|July 27, 2024
Rapid Detection of Cleanliness on Direct Bonded Copper Substrate by Using UV Hyperspectral ImagingMona Knoblich, Mohammad Al Ktash, Frank Wackenhut, et al.
Breast Cancer Research and Treatment|January 29, 2016
The effect of resistance training on markers of immune function and inflammation in previously sedentary women recovering from breast cancer: a randomized controlled trialAmanda D Hagstrom, Paul W M Marshall, Chris Lonsdale, et al.
Sensors (Basel, Switzerland)|November 13, 2021
UV Hyperspectral Imaging as Process Analytical Tool for the Characterization of Oxide Layers and Copper States on Direct Bonded CopperMohammad Al Ktash, Mona Stefanakis, Tim Englert, et al.
Blood|November 18, 2004
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen deliveryMax Schnurr, Qiyuan Chen, Amanda Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumorsEugene Maraskovsky, Sigrid Sjölander, Debbie P Drane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Pharmacodynamic effects of seliciclib, an orally administered cell cycle modulator, in undifferentiated nasopharyngeal cancerWen-Son Hsieh, Ross Soo, Bee-Keow Peh, et al.
Journal of Medicinal Chemistry|March 19, 2004
2-Anilino-4-(thiazol-5-yl)pyrimidine CDK inhibitors: synthesis, SAR analysis, X-ray crystallography, and biological activityShudong Wang, Christopher Meades, Gavin Wood, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvantQiyuan Chen, Heather Jackson, Phillip Parente, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2004
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humansIan D Davis, Weisan Chen, Heather Jackson, et al.
Pageof 9